Total Payments
$7,237
2024 Payments
$3,874
Companies
19
Transactions
89
Medicare Patients
4,362
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$3,416 (47.2%)
Travel$1,946 (26.9%)
Consulting$1,500 (20.7%)
Other$375.00 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,416 | 80 | 47.2% |
| Travel and Lodging | $1,946 | 7 | 26.9% |
| Consulting Fee | $1,500 | 1 | 20.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $375.00 | 1 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | $2,026 | 5 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $1,420 | 13 | $0 (2024) |
| Alcon Vision LLC | $1,349 | 22 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $1,141 | 9 | $0 (2024) |
| ABBVIE INC. | $280.21 | 12 | $0 (2023) |
| Sight Sciences, Inc. | $214.22 | 2 | $0 (2022) |
| Glaukos Corporation | $148.65 | 3 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $142.79 | 2 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $123.92 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $74.03 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,874 | 32 | Tarsus Pharmaceuticals, Inc. ($2,026) |
| 2023 | $1,058 | 25 | BIOTISSUE HOLDINGS, INC. ($350.78) |
| 2022 | $1,124 | 13 | BioTissue Holdings, Inc. ($733.92) |
| 2021 | $106.00 | 6 | Alcon Vision LLC ($21.29) |
| 2020 | $170.80 | 4 | Alcon Vision LLC ($170.80) |
| 2019 | $904.41 | 9 | Alcon Vision LLC ($780.49) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $0.68 | General |
| Category: Ophthalmology | ||||||
| 10/30/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $63.04 | General |
| Category: Ophthalmology | ||||||
| 10/13/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $55.96 | General |
| 10/09/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: Ophthalmology | ||||||
| 09/17/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/13/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/08/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Food and Beverage | In-kind items and services | $63.87 | General |
| Category: Ophthalmology | ||||||
| 06/08/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Food and Beverage | In-kind items and services | $45.62 | General |
| Category: Ophthalmology | ||||||
| 06/08/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Food and Beverage | In-kind items and services | $39.06 | General |
| Category: Ophthalmology | ||||||
| 06/08/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Ophthalmology | ||||||
| 06/08/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Travel and Lodging | In-kind items and services | $12.96 | General |
| Category: Ophthalmology | ||||||
| 06/07/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Travel and Lodging | In-kind items and services | $659.96 | General |
| Category: Ophthalmology | ||||||
| 06/07/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Travel and Lodging | In-kind items and services | $258.13 | General |
| Category: Ophthalmology | ||||||
| 06/07/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Food and Beverage | In-kind items and services | $114.05 | General |
| Category: Ophthalmology | ||||||
| 06/07/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Travel and Lodging | In-kind items and services | $40.96 | General |
| Category: Ophthalmology | ||||||
| 06/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/06/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $123.75 | General |
| Category: Ophthalmology | ||||||
| 06/03/2024 | Bausch & Lomb Americas Inc. | IC-8 Apthera IOL (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Ophthalmology | ||||||
| 04/24/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $52.80 | General |
| Category: Ophthalmology | ||||||
| 04/22/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 04/17/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 04/17/2024 | Tarsus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| 04/15/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Ophthalmology | ||||||
| 04/11/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,738 | 10,316 | $1.5M | $944,861 |
| 2022 | 22 | 1,756 | 3,566 | $1.4M | $896,871 |
| 2021 | 15 | 856 | 1,209 | $386,172 | $251,591 |
| 2020 | 1 | 12 | 12 | $27,840 | $2,028 |
Total Patients
4,362
Total Services
15,103
Medicare Billing
$2.1M
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 80 | 610 | $658,700 | $418,050 | 63.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 28 | 6,960 | $291,346 | $201,659 | 69.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 209 | 346 | $249,897 | $133,583 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 288 | 437 | $61,067 | $38,055 | 62.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 87 | 411 | $53,824 | $33,889 | 63.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 56 | 76 | $28,409 | $17,356 | 61.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 257 | $25,195 | $15,174 | 60.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 137 | 137 | $30,140 | $14,590 | 48.4% |
| 65820 | Incision to improve eye fluid flow | Facility | 2023 | 14 | 21 | $27,165 | $13,220 | 48.7% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 17 | 20 | $19,226 | $11,078 | 57.6% |
| 92134 | Imaging of retina | Office | 2023 | 159 | 378 | $16,688 | $10,959 | 65.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 244 | 373 | $28,191 | $10,891 | 38.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 106 | 118 | $16,189 | $10,479 | 64.7% |
| 65780 | Transplantation of fetal sac tissue to cornea | Facility | 2023 | 12 | 15 | $12,104 | $7,686 | 63.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 65 | 65 | $10,595 | $5,621 | 53.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 36 | 36 | $1,560 | $697.30 | 44.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 15 | 15 | $1,072 | $665.60 | 62.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 18 | 20 | $1,980 | $635.88 | 32.1% |
| 92025 | Ct scan of cornea | Office | 2023 | 19 | 21 | $850.00 | $571.61 | 67.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 87 | 792 | $854,212 | $568,206 | 66.5% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 198 | 319 | $227,283 | $121,396 | 53.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 285 | 388 | $54,258 | $33,072 | 61.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 87 | 397 | $49,625 | $32,714 | 65.9% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 68 | 101 | $34,944 | $23,596 | 67.5% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 31 | 42 | $40,160 | $23,478 | 58.5% |
About Dr. Peter Lam, MD
Dr. Peter Lam, MD is a Ophthalmology healthcare provider based in Victoria, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2015. The National Provider Identifier (NPI) number assigned to this provider is 1346624111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Lam, MD has received a total of $7,237 in payments from pharmaceutical and medical device companies, with $3,874 received in 2024. These payments were reported across 89 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,416).
As a Medicare-enrolled provider, Lam has provided services to 4,362 Medicare beneficiaries, totaling 15,103 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Victoria, TX
- Active Since 07/11/2015
- Last Updated 09/13/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346624111
Products in Payments
- enVista Aspire IOL (Device) $1,262
- PROKERA (Device) $857.99
- Centurion (Device) $444.02
- Clareon (Device) $354.85
- ReSTOR (Device) $284.39
- DURYSTA (Drug) $237.62
- OMNI(R) SURGICAL SYSTEM (US) (Device) $214.22
- EYLEA HD (Biological) $142.79
- MIEBO (Drug) $138.47
- Rhopressa (Drug) $123.92
- AcrySof (Device) $123.12
- XIIDRA (Drug) $74.03
- DEXTENZA (Drug) $55.43
- OXERVATE (Drug) $53.15
- OZURDEX (Drug) $42.19
- Vabysmo (Drug) $38.44
- XDEMVY (Drug) $27.19
- ILUVIEN (Drug) $24.54
- VUITY (Drug) $22.15
- AcrySof IQ PanOptix UV IOL (Device) $21.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Victoria
Daniel Bustos, M.d, M.D
Ophthalmology — Payments: $2,195
Ophthalmology $2,195
Dr. George Boozalis, M.d, M.D
Ophthalmology — Payments: $1,970
Ophthalmology $1,970
Robert Mcmahon, Md, MD
Ophthalmology — Payments: $1,600
Ophthalmology $1,600
He Li, Md, MD
Ophthalmology — Payments: $1,360
Ophthalmology $1,360
Robert Gilliam, M.d, M.D
Ophthalmology — Payments: $681.18
Ophthalmology $681.18